Correlation Between Curative Biotechnology and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Curative Biotechnology and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Curative Biotechnology and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Curative Biotechnology and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Curative Biotechnology and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Curative Biotechnology with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Curative Biotechnology and Vertex Pharmaceuticals.
Diversification Opportunities for Curative Biotechnology and Vertex Pharmaceuticals
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Curative and Vertex is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Curative Biotechnology and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Curative Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Curative Biotechnology are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Curative Biotechnology i.e., Curative Biotechnology and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Curative Biotechnology and Vertex Pharmaceuticals
Given the investment horizon of 90 days Curative Biotechnology is expected to generate 7.68 times more return on investment than Vertex Pharmaceuticals. However, Curative Biotechnology is 7.68 times more volatile than Vertex Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.46 per unit of risk. If you would invest 1.18 in Curative Biotechnology on November 9, 2024 and sell it today you would earn a total of 0.07 from holding Curative Biotechnology or generate 5.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Curative Biotechnology vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Curative Biotechnology |
| Vertex Pharmaceuticals |
Curative Biotechnology and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Curative Biotechnology and Vertex Pharmaceuticals
The main advantage of trading using opposite Curative Biotechnology and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Curative Biotechnology position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Curative Biotechnology vs. Biotron Limited | Curative Biotechnology vs. biOasis Technologies | Curative Biotechnology vs. Covalon Technologies | Curative Biotechnology vs. Mosaic Immunoengineering |
| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |